Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

5 big analyst picks: SAP snags 2 upgrades after Q1 miss | Pro Recap

Published 25/04/2023, 07:56 pm
Updated 25/04/2023, 07:56 pm
© Reuters.

Investing.com -- Here is your daily Pro Recap of the biggest analyst picks you may have missed since yesterday.

SAP receives two upgrades following Q1 miss

Citi upgraded SAP (NYSE:SAP) to Buy from Neutral and raised its price target to €150.00 from €120.00. Shares are up more than 1% pre-market today. Meanwhile, CFRA upgraded the company to Buy from Hold and raised its price target to $147.00 from $121.00.

As always, InvestingPro subscribers got this news first. Start your free 7-day trial to get on board.

The company reported its Q1 results on Friday. Despite the EPS miss and outlook cut, shares reacted positively to strong cloud revenue growth, closing the day with a 5% gain.

Zebra Technologies upgraded to Outperform, EMEA to drive EPS upside

Credit Suisse upgraded Zebra Technologies (NASDAQ:ZBRA) to Outperform from Neutral and raised its price target to $326.00 from $311.00 ahead of the upcoming Q1/23 earnings, scheduled on May 2.

The firm raised its fiscal 2023 EPS estimate to $17.70 driven by strength in the EMEA region, and better FX. According to Credit Suisse, its channel check suggests Q1 growth in the region to be mid-single to high-single digits (EMEA represents 33% of total sales). Thus, it raised its Q1 EPS estimate to $4.04 (vs. $3.92 consensus). Furthermore, it expects Q2 EPS guidance to be in the range of $4.10-4.40, compared to the $4.17 consensus.

3 more upgrades

BofA Securities upgraded Ally Financial (NYSE:ALLY) to Neutral from Underperform and raised its price target to $28.00 from $24.00.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Last week, the company reported its Q1 results, with EPS of $0.82 coming in worse than the consensus of $0.86, while revenues of $2.1 billion beat the consensus of $2.07B.

Barclays upgraded Universal Health Services (NYSE:UHS) to Equalweight from Underweight and raised its price target to $142.00 from $132.00.

The company reports its Q1 earnings today after the market close.

Goldman Sachs upgraded ZTO Express (NYSE:ZTO) to Buy from Neutral. Shares are up more than 1% pre-market today.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.